| Product Name | MF | CAS | Details |
|---|
| 2,3,4,6-Tetra-O-benzyl-a-D-glucopyranose | C34H36O6 | 6564-72-3 | Details |
| 4-(3-Methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid | C12H9NO4 | 83560-88-7 | Details |
| 4-(2-Methoxyphenyl)-3-methylbut-2-enoic acid | C12H14O3 | 1216328-65-2 | Details |
| Cdx2 antibody | Details |
| 1-Methyl-3-[(2S)-pyrrolidin-2-yl]-1H-1,2,4-triazol-5-amine dihydrochloride | C7H14ClN5 | 2230789-70-3 | Details |
| SGTA protein (His tag) | Details |
| H-PPEAPAEDRSL-OH | Details |
| H-ETINEEAAE-OH | Details |
| Glucobarbarin potassium salt | C15H20NO10S2.K | 21087-78-5 | Details |
| 2-{[(tert-Butoxy)carbonyl]amino}-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpropanoic acid | 2378503-55-8 | Details |
| Bromophos-methyl-oxon | C8H8BrCl2O4P | 4855-62-3 | Details |
| Lirilumab | 1000676-41-4 | Details |
| 2'-Hydroxy-4'-methoxypropiophenone | C10H12O3 | 6270-44-6 | Details |
| 4-Phenylbut-3-ynoic acid | C10H8O2 | 7218-49-7 | Details |
| FGF basic (1-24) (human, bovine) | C118H173N31O33 | 211362-85-5 | Details |
| DL-Pyroglutamic acid | C5H7NO3 | 149-87-1 | Details |
| SARS-CoV-2 Membrane protein (172-188) | Details |
| 4,4'-Diiodo-2,2'-biphenol | C12H8I2O2 | 204315-81-1 | Details |
| (1R)-1-Cyclopropyl-2,2-difluoroethan-1-amine hydrochloride | C5H10ClF2N | 2089671-56-5 | Details |
| 1,2-Ethanedithiol | C2H6S2 | 540-63-6 | Details |
| 3-oxiranyl-7-Oxabicyclo[4.1.0]heptane, mixture of isomers | C8H12O2 | 106-87-6 | Details |
| RS-246204 | C16H13N5O2S | 878451-87-7 | Details |
| 4-Methyl-2-(pyrrolidin-2-yl)-1,3-thiazole | C8H12N2S | 933682-46-3 | Details |
| rac-(2R,3R)-2-(1-Ethyl-1H-imidazol-2-yl)oxolan-3-amine dihydrochloride | C9H16ClN3O | 2059908-19-7 | Details |
| CNTNAP1 antibody | Details |
| 1-(Difluoromethyl)-3-nitro-1H-1,2,4-triazole | C3H2F2N4O2 | 2137653-18-8 | Details |
| Nemoralisin C | C20H28O5 | 1443421-84-8 | Details |
| 1,4-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihexylbenzene | C30H52B2O4 | 374934-77-7 | Details |
| Sucrose monopalmitate | C28H52O12 | 24516-45-8 | Details |
| 1-Bromo-2-chloro-3-iodobenzene | C6H3BrClI | 57012-50-7 | Details |
| 2-(2-Chlorophenyl)ethanol | C8H9ClO | 19819-95-5 | Details |
| 8,12-Iso-ipf2α-VI | C20H34O5 | 1445349-99-4 | Details |
| FF-MAS | C29H46O | 64284-64-6 | Details |
| H-LADGGATNQGR-OH | Details |
| 1,4-Phenylenediamine dihydrochloride | C6H10Cl2N2 | 624-18-0 | Details |
| Methyl 1-Boc-2-pyrrolidinecarboxylate | C11H19NO4 | 145681-01-2 | Details |
| Fluticasone propionate dithioacid | Details |
| 2-Acetamido-1,3-di-O-acetyl-4,6-O-benzylidene-2-deoxy-D-glucopyranose | C19H23NO8 | 1423035-26-0 | Details |
| 3-Amino-1-{4-[(difluoromethyl)sulfanyl]phenyl}thiourea | C8H9F2N3S2 | 721910-08-3 | Details |
| 5alpha-Pregnan-3beta,17alpha-diol-20-one | C21H34O3 | 570-54-7 | Details |
| Gatifloxacin hydrochloride | C22H28FN3O7 | 160738-57-8 | Details |
| 4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | C14H18BNO2 | 863868-22-8 | Details |
| [5-(Dimethoxymethyl)-2-fluorophenyl]methanol | C10H13FO3 | 334019-16-8 | Details |
| GALNT5 antibody | Details |
| Mouse IL9 ELISA kit | Details |
| KIF2C Blocking Peptide | Details |
| Valproic acid related compound A | C8H12O2 | 99-67-2 | Details |
| 2,5-Diiodoaniline | C6H5I2N | 64085-53-6 | Details |
| 3-(Quinolin-3-yl)propanoic acid | C12H11NO2 | 67752-28-7 | Details |
| 6-benzyl-2-methyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one | C15H17N3O | 1448-40-4 | Details |
| 3-iso-Propoxybenzyl alcohol | C10H14O2 | 26066-15-9 | Details |
| 1-(4-Chlorophenyl)-5-ethyl-1H-pyrazol-4-amine hydrochloride | C11H13Cl2N3 | 1788596-62-2 | Details |
| (2,2,3,3-Tetramethylcyclopropyl)methanol | C8H16O | 2415-96-5 | Details |
| 3-Amino-5-chloro-2-methoxypyridine | C6H7ClN2O | 886373-70-2 | Details |
| [1-(Propan-2-yl)-1H-1,2,4-triazol-5-yl]methanamine hydrochloride | C6H13ClN4 | 2375271-05-7 | Details |
| BUB1B antibody | Details |
| (2R)-1-Ethoxypropan-2-amine hydrochloride | C5H14ClNO | 2241107-55-9 | Details |
| 1-(4-Methylphenyl)-1H,4H,5H,6H-cyclopenta[C]pyrazole-3-carboxylic acid | C14H14N2O2 | 926261-82-7 | Details |
| 1,2:3,4-Diacetone-β-D-glucopyranoside | C12H20O6 | 496879-67-5 | Details |
| 4-(3-Formylphenoxy)butanoic acid | C11H12O4 | 174884-10-7 | Details |
| (3R)-3-Amino-2,3,4,5-tetrahydro-1,5-benzoxazepin-4-one hydrochloride | C9H11ClN2O2 | 639478-67-4 | Details |
| (Propan-2-yl)[1-(thiophen-3-yl)ethyl]amine | C9H15NS | 1250599-64-4 | Details |
| tert-Butyl 4-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate | 2375274-28-3 | Details |
| Lacto-N-hexaose | C40H68N2O31 | 64003-51-6 | Details |
| SARS-CoV-2 Spike Receptor-Binding Domain (RBD) Mouse Monoclonal Antibody | Details |
| 7-Amino-5-oxo-4H,5H-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid | C7H6N4O3 | 197367-86-5 | Details |
| Methyl 2-[(2R,4R)-4-fluoropyrrolidin-2-yl]acetate hydrochloride | 2219353-54-3 | Details |
| YWHAH antibody | Details |
| Biotin-dPEG?11-Lipoamide | C42H87N4O14S3 | 960069-81-2 | Details |
| Anti-Human IgM | Details |
| 1a,1b-Dihomo prostaglandin E2 | C22H36O5 | 26198-80-1 | Details |
| [4-(1,3-Dioxaindan-5-yl)butan-2-yl]hydrazine dihydrochloride | C11H16N2O2.2ClH | 1803586-36-8 | Details |
| NECAP1 antibody | Details |
| 2-Thiopseudouridine | C9H12N2O5S | 59464-18-5 | Details |
| (4-(1H-Pyrazol-3-yl)phenyl)methanol | C10H10N2O | 179057-16-0 | Details |
| N-(4-((1,3-dioxoindan-2-ylidene)methyl)phenyl)ethanamide | C18H13NO3 | 31060-55-6 | Details |
| 2-[(3-Nitrophenyl)formamido]acetic acid | C9H8N2O5 | 617-10-7 | Details |
| 2-Methylpiperidine-1-carbonyl chloride | C7H12ClNO | 64196-60-7 | Details |
| 3-[4-(Trifluoromethyl)phenyl]pentan-3-amine hydrochloride | C12H17ClF3N | 667916-89-4 | Details |
| 4-(Dimethyl-4H-1,2,4-triazol-3-yl)butanoic acid | C8H13N3O2 | 1249819-92-8 | Details |
| DSCAM antibody | Details |
| Boc-Leu-Gly-Arg-pNA | C25H40N8O7 | 68223-96-1 | Details |
| 3-Chloropropionic anhydride | C6H8Cl2O3 | 20495-99-2 | Details |
| 4-(Heptylsulfanyl)benzoic acid | C14H20O2S | 32910-58-0 | Details |
| HSV2 antibody (FITC) | Details |
| 1-(4-Chlorophenyl)cyclopropan-1-ol | C9H9ClO | 16031-54-2 | Details |
| 5-Azido-2-C-(benzylaminomethyl)-5-deoxy-2,3-O-isopropylidene-L-lyxonic acid b-lactam | Details |
| SARS-CoV-2 Spike (996-1004) | Details |
| Cholecalciferol impurity A | C27H44O | 22350-41-0 | Details |
| [(1S)-1-cyclohexylethyl](methyl)amine | C9H19N | 138785-57-6 | Details |
| 1-(3-Chlorophenyl)-6-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one | C12H9ClN4O | 1097095-35-6 | Details |
| 5-(Chloromethyl)-3-methyl-1-phenyl-1H-pyrazole-4-carbonitrile | C12H10ClN3 | 698367-00-9 | Details |
| 3-(4-ethoxyphenyl)-1,2-oxazol-5-amine | C11H12N2O2 | 54606-18-7 | Details |
| 1-(2-Phenylethyl)-1H-pyrazole-3-carboxylic acid | C12H12N2O2 | 1342765-18-7 | Details |
| MYOM3 antibody | Details |
| UBR2 Blocking Peptide | Details |
| 3-(Propan-2-yl)-1H-pyrazole-5-carbaldehyde | C7H10N2O | 956723-08-3 | Details |
| (2-Chlorophenyl)-n-methyl-n-benzamide | C14H12ClNO | 7022-47-1 | Details |
| 4-(3-Fluorophenyl)pyrrolidin-2-one | C10H10FNO | 1019650-87-3 | Details |
| 2-[(3-Chlorophenyl)methoxy]acetic acid | C9H9ClO3 | 868277-51-4 | Details |
| Product Total： Product Page： | ||||
| 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 | ||||